Company History

  • Mar 2014

    Guizhou Taibang received the renewed Good Manufacturing Practice ("GMP") certification from China Food and Drug Administration ("CFDA") in respect of its updated plasma production facility.
  • January 2014

    Guizhou Taibang received the renewed Good Manufacturing Practice ("GMP") certification from China Food and Drug Administration ("CFDA") in respect of its updated placenta polypeptide production facility.
  • January 2014

    China Biologic repurchased 2,500,000 shares of common stock from one of its individual shareholders for a consideration of $70,000,000.
  • October 2013

    Forbes magazine again named China Biologic to its annual list of Asia’s “200 Best Under a Billion.
FirstPage | PreviousPage | NextPage | LastPage CurrentPageIndex:2 [1] [2] [3] [4] [5] [6] [7] 
© 2014 China Biologic Products, Inc. All Rights Reserved.